WASHINGTON/NEW YORK – A U.S. congressional committee has demanded that former drug executive Martin Shkreli appear in a hearing on drug prices to testify about his former company’s decision to boost the cost of a lifesaving medicine by a lot more than 5,000 percent, congressional aides said on Wednesday. Shkreli, who is separately facing federal criminal charges that he defrauded ...
Read More »